Testing effectiveness (Phase 2)Study completedNCT01183897
What this trial is testing
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow
Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 31